Cohen & Steers, Inc. — News

HOUSTON, July 21, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of  Plus Therapeutics, Inc.  (Nasdaq:  PSTV ) (“Plus” or the “Company”), announced today that it has signed a regional agreement with Medical Mutual effective July 1, 2026, covering approximately 1.2 million people throughout Ohio and Kentucky, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) assay. This brings CNSide CSF TCE assay total contracted coverage to approximately 127 million people.

globenewswire.com - 2026-07-21 07:30:00

NEW YORK, July 20, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today the appointment of Erik Schneberger as Executive Vice President, Chief Marketing Officer. Based in New York, Mr.

prnewswire.com - 2026-07-20 09:00:00

Cohen & Steers, Inc. is now rated Hold after a strong rally closed the prior valuation gap. CNS's Q2 saw net inflows of $1.3B and AUM rise to $100.1B, signaling renewed interest in public real estate. Operating margin expanded to 36.3% on revenue growth, with scope to reach 37% in H2 if markets remain stable.

seekingalpha.com - 2026-07-17 13:31:22

Cohen & Steers, Inc. (CNS) Q2 2026 Earnings Call Transcript

seekingalpha.com - 2026-07-17 13:16:20

Cohen & Steers NYSE: CNS reported higher second-quarter 2026 adjusted earnings and assets under management, as executives pointed to improving demand for real estate, infrastructure, preferred securities and broader real assets strategies.

marketbeat.com - 2026-07-17 11:04:18

NEW YORK, July 16, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported its results for the quarter ended June 30, 2026. The earnings release along with the accompanying earnings presentation can be viewed at Cohen & Steers Reports Results for Second Quarter 2026 and on the company's website at www.cohenandsteers.com under "Company—Investor Relations—Earnings Archive.

prnewswire.com - 2026-07-16 16:34:00

NEW YORK, July 16, 2026 /PRNewswire/ -- Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") today announced the results of its transferable rights offering (the "Offer"), which commenced on June 18, 2026 and expired on July 15, 2026 (the "Expiration Date"). The Offer was led by UBS Investment Bank as the sole dealer manager.

prnewswire.com - 2026-07-16 09:00:00

Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient monitoring Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient monitoring

globenewswire.com - 2026-07-14 07:30:00

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders, today announced results from a new healthcare claims study of treatment patterns of newly diagnosed and established GAD patients, including pharmacotherapy use, discontinuation, switching and treatment progression. The fi.

businesswire.com - 2026-07-14 07:00:00

Cohen & Steers, Inc. (CNS) is rated BUY, driven by strong fund inflows, accelerating REIT performance, and a 37% forward P/E discount versus historical peaks. Cohen & Steers' AUM reached $93 billion in Q1 2026, with 86% of AUM outperforming benchmarks over one year and 98% over three years. REITs, comprising 48% of AUM, are benefiting from sector rotation, improved property fundamentals, and have delivered double-digit YTD returns.

seekingalpha.com - 2026-07-13 15:32:13

Retirement income requires more than just high yield. REIT funds may not be the best solution. A balanced REIT portfolio can offer income and growth.

seekingalpha.com - 2026-07-11 07:15:00

NEW YORK, July 9, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $100.1 billion as of June 30, 2026, an increase of $644 million from assets under management of $99.5 billion at May 31, 2026. The increase was due to market appreciation of $611 million and net inflows of $495 million, partially offset by distributions of $462 million.

prnewswire.com - 2026-07-09 16:23:00

NEW YORK, July 8, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced that it expects to release second quarter 2026 results after the market closes on Thursday, July 16, 2026. The earnings release and accompanying earnings presentation will be available on the company's website at www.cohenandsteers.com under "Company—Investor Relations—Earnings Archive.

prnewswire.com - 2026-07-08 16:28:00

NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on June 30, 2026 and cumulative distributions paid fiscal year-to-date. In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-06-29 18:26:00

NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the distribution to be paid on June 30, 2026 and cumulative distributions paid fiscal year-to-date. In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-06-29 18:23:00

NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on June 30, 2026 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-06-29 18:19:00

NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on June 30, 2026 and cumulative distributions paid fiscal year-to-date. In December 2017, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-06-29 18:04:00

NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of the distribution to be paid on June 30, 2026 and cumulative distributions paid fiscal year-to-date. In December 2012, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-06-29 18:00:00

HOUSTON, June 25, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with Elevance Health, Inc. (NYSE: ELV), effective May 1, 2026, covering approximately 45.4 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) assay. This brings CNSide CSF TCE assay total contracted coverage to 126 million people.

globenewswire.com - 2026-06-25 07:30:00

Cohen & Steers, Inc. offers institutional-quality closed-end funds focused on real assets and alternative income, with a recent real estate sell-off creating attractive entry points. Fund sectors include real estate, preferred securities, infrastructure, utilities, and fixed income. C&S's expertise in alternatives, active management, and reliable monthly distributions make their CEFs excellent tools for diversification and steady income.

seekingalpha.com - 2026-06-24 17:02:34

SAN FRANCISCO and BOSTON, June 24, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system (CNS) disorders, today announced the appointment of Martin Babler and Troy Cox to its Board of Directors following their election at the Company's Annual Meeting of Stockholders on June 23, 2026. Mr. Babler and Mr. Cox succeed Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., who did not stand for re-election and have concluded their service on the Board. Mr. Babler has been appointed as a member of the Audit Committee, and Mr. Cox has been appointed Chair of the Nominating and Corporate Governance Committee.

globenewswire.com - 2026-06-24 07:00:00

CUPERTINO, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, PhD.

globenewswire.com - 2026-06-23 08:00:00

Management to update on 2026 mid-year progress, milestones and provide details on its integrated CNS oncology strategy and artificial intelligence plans Management to update on 2026 mid-year progress, milestones and provide details on its integrated CNS oncology strategy and artificial intelligence plans

globenewswire.com - 2026-06-23 07:30:00

Partnership delivers real-time DDoS protection and cyber resilience solutions to enterprises, service providers, and critical infrastructure organizations LONDON, June 23, 2026 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), leader in real-time DDoS protection and service availability, today announced a strategic partnership with ITcare, a leading provider of technology and managed services solutions. Through this partnership, ITcare will offer Corero's SmartWall ONE™ platform to help organizations defend against increasingly sophisticated Distributed Denial of Service (DDoS) attacks while maintaining business continuity and service availability.

prnewswire.com - 2026-06-23 07:00:00

NEW YORK, June 22, 2026 /PRNewswire/ -- The Board of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for July, August and September 2026, as summarized in the charts below: Ticker Fund Name Monthly Dividend FOF Cohen & Steers Closed-End Opportunity Fund, Inc. $0.087 LDP Cohen & Steers Limited Duration Preferred and Income Fund, Inc. $0.131 PSF Cohen & Steers Select Preferred and Income Fund, Inc. $0.126 PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund $0.134 RFI Cohen & Steers Total Return Realty Fund, Inc. $0.080 RLTY Cohen & Steers Real Estate Opportunities and Income Fund $0.110 RNP Cohen & Steers REIT and Preferred and Income Fund, Inc. $0.136 UTF Cohen & Steers Infrastructure Fund, Inc. $0.165 Distributions will be made on the following schedule: Month Ex-Dividend/ Record Date Payable Date July  Jul. 14, 2026  Jul. 31, 2026 August Aug. 11, 2026 Aug. 31, 2026 September Sept. 8, 2026 Sept.

prnewswire.com - 2026-06-22 18:57:00

CAMBRIDGE, Mass., June 22, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates in the neuroimmune area of the central nervous system (CNS).

prnewswire.com - 2026-06-22 00:37:00

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it is joining patients, caregivers, and advocacy organizations in raising awareness of brain health and the impact of Alzheimer's disease during Alzheimer's & Brain Awareness Month. “Nearly everyone knows brain health is important, but many people aren't sure what steps to take to protect it,” said Wendy Vizek, Senior Vice President, Community Engagement and Field Operations at the Alzheimer's Association.

globenewswire.com - 2026-06-18 07:00:00

PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the appointment of Bethany Mancilla as Chief Business Officer. Ms. Mancilla brings a breadth of corporate development experience across large and small biotechnology companies, including an extensive history of transactions in gene therapy and central nervous system (CNS) disorders. “Bethany joins Latus at a defining moment as we advance LTS-201 toward th.

businesswire.com - 2026-06-16 07:00:00

NEW YORK, June 15, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced it has completed the conversion the Cohen & Steers Future of Energy Fund (MLOIX) into a new, actively managed exchanged-traded fund (ETF), the Cohen & Steers Future of Energy Active ETF (CSEN). CSEN, listed today on Nasdaq with $189 million in assets, expands Cohen & Steers' actively managed real assets and alternative income ETF platform to more than $1 billion in assets under management[1].

prnewswire.com - 2026-06-15 09:50:00

CORAL GABLES, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced the appointment of Michael Quirk, PhD, as Senior Advisor – Sepranolone Program. Dr. Quirk's deep expertise in CNS translational science, neuroactive steroid biology, and clinical development will be instrumental in advancing sepranolone, Relmada's GABAA receptor modulator program targeting Prader-Willi Syndrome and other CNS indications.

globenewswire.com - 2026-06-11 07:00:00

NEW YORK, June 8, 2026 /PRNewswire/ -- The Board of Directors of the Cohen & Steers Quality Income Realty Fund, Inc. (the "Fund") announced today the monthly distributions for July, August and September 2026, as summarized in the charts below: Ticker Fund Name Monthly Dividend RQI Cohen & Steers Quality Income Realty Fund, Inc. $0.090 The distribution will be made on the following schedule: Month Ex-Dividend/ Record Date Payable Date July Jul. 6, 2026 Jul. 31, 2026 August Aug. 11, 2026 Aug. 31, 2026 September Sept. 8, 2026 Sept.

prnewswire.com - 2026-06-08 16:20:00

NEW YORK, June 8, 2026 /PRNewswire/ -- Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") announced today that its Board of Directors has approved the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common stock (par value $0.001 per share), as of the record date, June 18, 2026 (the "Record Date"). Holders of these Rights will be entitled to subscribe for additional shares of common stock (the "Offer").

prnewswire.com - 2026-06-08 16:17:00

NEW YORK, June 8, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $99.5 billion as of May 31, 2026, a decrease of $645 million from assets under management of $100.1 billion at April 30, 2026. The decrease was due to market depreciation of $592 million and distributions of $154 million, partially offset by net inflows of $101 million.

prnewswire.com - 2026-06-08 16:15:00

Access the segment here HOUSTON, TX / ACCESS Newswire / June 8, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in a Virtual Investor "What This Means" Segment. Steve O'Loughlin, Chief Financial Officer of CNS Pharmaceuticals, discussed the Company's recently completed oversubscribed $22.5 million financing in the virtual segment, addressing the factors that enabled the successful capital raise following its strategic reset and acquisition-focused transformation.

accessnewswire.com - 2026-06-08 09:15:00

Axsome Therapeutics NASDAQ: AXSM executives said the company is preparing to launch Auvelity in Alzheimer's disease agitation this month while continuing to expand the drug's use in major depressive disorder and advance a broad central nervous system pipeline.

marketbeat.com - 2026-06-06 00:02:38

Johnson and Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2

gurufocus.com - 2026-06-03 01:00:00

Johnson and Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease

gurufocus.com - 2026-06-03 01:00:00

NEW YORK, June 2, 2026 /PRNewswire/ -- Cohen & Steers Income Opportunities REIT, Inc. ("CNSREIT") announced today its acquisition of Oracle Crossings, a 266,000‑square‑foot, grocery‑anchored open‑air shopping center located in the Oro Valley submarket of Tucson, Arizona. The acquisition was completed through CNSREIT's programmatic joint venture with Phillips Edison & Company (NASDAQ: PECO – "PECO"), a publicly traded owner and operator of grocery‑anchored U.S. shopping centers.

prnewswire.com - 2026-06-02 08:45:00

Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with ea

gurufocus.com - 2026-05-31 09:00:00

Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neur

gurufocus.com - 2026-05-30 15:00:00

/PRNewswire/ -- Cohen and Steers, Inc. (NYSE: CNS) today announced that three funds of the Cohen and Steers SICAV - the Global Listed Infrastructure Fund, the

prnewswire.com - 2026-05-28 04:00:00

NEW YORK, May 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on May 29, 2026 and cumulative distributions paid fiscal year-to-date. In December 2017, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-05-27 18:04:00

NEW YORK, May 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on May 29, 2026 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-05-27 18:02:00

NEW YORK, May 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of the distribution to be paid on May 29, 2026 and cumulative distributions paid fiscal year-to-date. In December 2012, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-05-27 18:01:00

NEW YORK, May 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the distribution to be paid on May 29, 2026 and cumulative distributions paid fiscal year-to-date. In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-05-27 17:58:00

NEW YORK, May 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on May 29, 2026 and cumulative distributions paid fiscal year-to-date. In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

prnewswire.com - 2026-05-27 17:47:00

NEW YORK, May 21, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced that Amit Muni has been appointed as Executive Vice President and Chief Financial Officer, effective June 8, 2026. Mr. Muni will lead the firm's financial operations, financial strategy and investor relations.

prnewswire.com - 2026-05-21 16:30:00

Cohen and Steers Announces Strategic Partnership with J.P. Morgan to Expand Access to Short Duration Hybrid Credit SICAV Strategy

gurufocus.com - 2026-05-20 22:00:00

NEW YORK, May 20, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS), today announced it is partnering with J.P. Morgan to provide access to the Cohen & Steers SICAV Short Duration Hybrid Credit & Income Fund for investors outside the United States across J.P.

prnewswire.com - 2026-05-20 21:00:00

/PRNewswire/ -- Cohen and Steers, Inc. (NYSE: CNS), today announced it is partnering with J.P. Morgan to provide access to the Cohen and Steers SICAV Short

prnewswire.com - 2026-05-20 21:00:00